Adam Feuerstein articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/10/30 21:23
2014/10/30 21:23
20h
One hedge fund manager who owns Aegerion believes investors should judge Beer more by his actions as CEO than what he does in his personal life. He asked not to be identified by name and he doesn't...
2014/10/30 21:23
2014/10/30 21:23
Latest videos
2014/10/30 21:23
2014/10/30 21:23
20h
Third quarter sales of Juxtapid, Aegerion's cholesterol-lowering drug, were 43.7 million, well off the $49 million consensus expected by the Street. Aegerion cut 2014 revenue guidance to a range of...
2014/10/27 17:22
2014/10/27 17:22
4d
Divorce Suit Names CEOs Involved in Cocaine Use, Extramarital Sex Romps A dirty divorce for one of Wall Street's top bankers just got messier. Sage Kelly is the global head of health care investment...
2014/10/24 13:22
2014/10/24 13:22
7d
Stuart A. writes: "Adam, Rockwell Medical has an FDA advisory committee meeting coming up soon. Can you talk about the issues that might be raised there?" The Food and Drug Administration is...
2014/10/23 14:22
2014/10/23 14:22
8d
TEL AVIV, Israel ( TheStreet) -- Alcobra(ADHD) disclosed in a regulatory filing Wednesday night new details about the phase III study of attention-deficit hyperactivity disorder drug candidate MDX...
2014/10/21 10:22
2014/10/21 10:22
10d
Mapp already has a manufacturing partner for ZMapp -- Kentucky BioProcessing, a unit of the diversified industrial, Reynolds American(RAI) . Let's assume that Mapp and Kentucky BioProcessing part ways...
2014/10/17 23:22
2014/10/17 23:22
13d
NEW YORK (TheStreet) -- Shares of Sarepta Therapeutics(SRPT) are soaring this morning following the publication of Phase I clinical study results for its Ebola and Marburg virus drug candidates....
2014/10/16 13:22
2014/10/16 13:22
15d
NEW YORK (TheStreet) -- Halfway through my two-hour phone conversation with Tony Fiorino last week, I asked the health care hedge fund investor-turned-CEO of Brainstorm Cell Therapeutics(BCLI) why he...
2014/10/10 19:22
2014/10/10 19:22
20d
Gilead Sciences(GILD) has secured U.S. approval for Harvoni, a new combination hepatitis C therapy, according to an announcement by the U.S. Food and Drug Administration. Harvoni is a single,...
2014/10/10 18:22
2014/10/10 18:22
20d
Gilead Sciences(GILD) has secured U.S. approval for Harvoni, a new combination hepatitis C therapy, according to an announcement from the U.S. Food and Drug Administration. Harvoni is a single,...
2014/10/10 11:22
2014/10/10 11:22
21d
Industry Recommendation: Crosswalk to Code 81315 (PML/RARalpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (eg, promyelocytic leukemia) translocation analysis; common...
2014/10/08 20:42
2014/10/08 20:42
22d
While I was finishing my morning post on brincidofovir’s preliminary efficacy in immunocompromised patients with adenoviral infections, the announcement came that Thomas Eric Duncan had succumbed to...
2014/10/08 12:22
2014/10/08 12:22
23d
BOSTON ( TheStreet) -- Washington Post business columnist Steven Pearlstein accused me -- falsely -- of working with short-selling hedge funds to manipulate stock prices and force small biotech...
2014/10/06 19:22
2014/10/06 19:22
24d
Updated from 6:38 am ET with additional information. TEL AVIV (TheStreet) -- Treatment with an experimental formulation of vitamin B6 known as MDX failed to improve the symptoms of attention-deficit...
2014/10/06 11:22
2014/10/06 11:22
25d
SOUTH SAN FRANCISCO ( TheStreet) -- Sunesis Pharmaceuticals(SNSS) announced the failure of a phase III study Monday morning. The company's experimental drug vosaroxin did not extend survival of...
2014/10/06 11:22
2014/10/06 11:22
25d
Note: This article discusses one or more stocks with a market cap between $350 million and $2 billion. Such small-cap stocks tend to be volatile. NEW YORK (TheStreet) -- Imagine being jet lagged for...
2014/10/01 14:22
2014/10/01 14:22
30d
NEW YORK ( TheStreet) -- Ebola is here, so for daytraders of biotech and drug stocks, Wednesday is going to be their Best. Day. Ever. A guy traveling from Liberia to Dallas was diagnosed with the...
2014/09/30 11:22
2014/09/30 11:22
1m
Catalyst reported positive results from a phase III study of Firdapse as a treatment for Lambert-Eaton Myasthenic Syndrome (LEMS), a progressive, muscle-weakening disease. Treatment with Firdapse...
2014/09/29 14:22
2014/09/29 14:22
m
In the study (known as AETHERA), treatment with Adcetris in "high risk" Hodgkin lymphoma patients immediately after a stem-cell transplant led to a 43% reduction in the risk of disease progression...
2014/09/27 22:19
2014/09/27 22:19
m
The past couple of weeks should have been heady ones for Bethesda-based Northwest Biotherapeutics. The small biotech firm, with an innovative new vaccine treatment for brain, prostate and other...
2014/10/30 21:23
2014/10/30 21:23
Latest from Twitter